ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC
Addiction (Substance Use Disorder) Counselor in PRINCETON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC filed 871 Medicare Part D claims in 2023 as a Addiction (Substance Use Disorder) Counselor in PRINCETON, New Jersey, prescribing 90% generic.
- 871
- Part D claims, 2023
- 90%
- generic prescribing
- $1.3K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
871 Top 27% higher than 73% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Addiction (Substance Use Disorder) Counselor compares to other specialties among New Jersey providers
Addiction (Substance Use Disorder) Counselor share within New Jersey
Addiction (Substance Use Disorder) Counselor is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Addiction (Substance Use Disorder) Counselor (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Addiction (Substance Use Disorder) Counselor ABMS/AOA estimate
Est. board-certified rate (Addiction (Substance Use Disorder) Counselor) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Addiction (Substance Use Disorder) Counselor US NPIs
Specialty board-certified rate — Addiction (Substance Use Disorder) Counselor estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC appears in the CMS NPPES registry as a Addiction (Substance Use Disorder) Counselor provider holding APN, LPC, LCADC credentials at 12 ROSZEL RD STE A103, PRINCETON, NJ, 08540, with a listed phone of (609) 419-0123. NPI 1831310309 was issued on 05/01/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TRAPANI-BARNACZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 871 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $159K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Addiction (Substance Use Disorder) Counselor is a high-volume specialty nationwide, with 109,141 enrolled providers across 55 states and an average of 645 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1831310309 |
|---|---|
| Specialty | Addiction (Substance Use Disorder) Counselor |
| Credentials | APN, LPC, LCADC |
| Gender | Female |
| NPI Issued | 05/01/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC. Source: openpaymentsdata.cms.gov.
Total received
$1.3K
Largest payer
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
10% brand-name claims vs 90% generic, on 871 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,691
- Total Day Supply
- 50,272
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $129K
- Generic Drug Cost
- $31K
Patient Demographics
- Average Patient Age
- 69.8 years
- Avg HCC Risk Score
- 1.08
- Gender Split
- 53% female / 47% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribes most
Top Medicare Part D drugs by claim count, 2023
- Lamotrigine
Lamotrigine
112 claims
- Clonazepam
Clonazepam
94 claims
- Duloxetine Hcl
Duloxetine Hcl
49 claims
- Buspirone Hcl 39
Buspirone Hcl
39 claims
- Bupropion Xl 35
Bupropion Xl
35 claims
- Desvenlafaxine Suc… 35
Desvenlafaxine Succinate Er
35 claims
- Gabapentin 29
Gabapentin
29 claims
- Levothyroxine Sodium 27
Levothyroxine Sodium
27 claims
| Drug | Claims |
|---|---|
| Lamotrigine | 112 |
| Clonazepam | 94 |
| Duloxetine Hcl | 49 |
| Buspirone Hcl | 39 |
| Bupropion Xl Bupropion Hcl | 35 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 35 |
| Gabapentin | 29 |
| Levothyroxine Sodium | 27 |
| Aripiprazole | 26 |
| Escitalopram Oxalate | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Addiction (Substance Use Disorder) Counselor Overview
How ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC fits within the Addiction (Substance Use Disorder) Counselor landscape nationally.
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's 871 claims are above the specialty average of 645.
Nearby Addiction (Substance Use Disorder) Counselor Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as TRAPANI-BARNACZ.
Compare Addiction (Substance Use Disorder) Counselor nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's specialty? ▼
How much does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe under Medicare Part D? ▼
Where is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC located? ▼
What is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's NPI number? ▼
Does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe more brand-name or generic drugs? ▼
How many Addiction (Substance Use Disorder) Counselor providers are there in the US? ▼
What drugs does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe most often? ▼
Does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC accept Medicare? ▼
How can I verify ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology